Bicycle Therapeutics plc: Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Continued clinical progress across pipeline, including dosing of the first patient in expansion cohorts of Phase I/II study of BT5528 Expansion of Genentech exclusive strategic collaboration, triggering
Source: finanznachrichten.de